Elevated cholestatic liver enzymes: Difference between revisions
From IDWiki
(Created page with "== Background == * Refers to a rise in ALP and GGT +/- bilirubin that is much more pronounced than any rise in ALT == Differential Diagnosis == === Marked Elevation === * Extrhepatic biliary obstruction ** Choledocholithiasis ** Cancer of the pancreas, gallbladder, ampulla of Vater, biliary duct, or perihilar lymph nodes ** Biliary strictures *** Primary sclerosing cholangitis with extrahepatic bile duct stricture *** Procedural complica...") |
No edit summary |
||
| Line 1: | Line 1: | ||
== Background == |
== Background == |
||
* Refers to a rise in ALP and GGT +/- bilirubin that is much more pronounced than any rise in ALT |
* Refers to a rise in [[ALP]] and [[GGT]] +/- bilirubin that is much more pronounced than any rise in ALT |
||
* [[ALP]] can also come from bone and placenta |
|||
== Differential Diagnosis == |
== Differential Diagnosis == |
||
| Line 29: | Line 30: | ||
** Hepatic crisis of sickle cell disease |
** Hepatic crisis of sickle cell disease |
||
** Others: IgG4 cholangiopathy, ischemic cholangiopathy, [[COVID-19]] |
** Others: IgG4 cholangiopathy, ischemic cholangiopathy, [[COVID-19]] |
||
== Investigations == |
|||
* Liver/biliary ultrasound to help differentiate between extrahepatic cholestasis (if biliary dilatation is seen) versus intrahepatic |
|||
* For intrahepatic cholestasis |
|||
** First order AMA (for PBC), ANA, anti-smooth muscle antibodies |
|||
** Then consider MRCP, hepatitis A, B, C, and E testing, and EBV and CMV testing |
|||
** Finally, consider liver biopsy |
|||
Revision as of 02:19, 11 July 2022
Background
- Refers to a rise in ALP and GGT +/- bilirubin that is much more pronounced than any rise in ALT
- ALP can also come from bone and placenta
Differential Diagnosis
Marked Elevation
- Extrhepatic biliary obstruction
- Choledocholithiasis
- Cancer of the pancreas, gallbladder, ampulla of Vater, biliary duct, or perihilar lymph nodes
- Biliary strictures
- Primary sclerosing cholangitis with extrahepatic bile duct stricture
- Procedural complication of ERCP
- Chronic pancreatitis resulting in stricture of the distal bile duct
- Anastomotic stricture of the bile duct after liver transplantation
- Infection: AIDS cholangiopathy, Ascaris lumbricoides, liver fluke
- Intrahepatic cholestasis
- Drugs and toxins
- Primary biliary cholangitis
- Primary sclerosing cholangitis
- Intrahepatic cholestasis of pregnancy
- Benign postoperative cholestasis
- Total parenteral nutrition
- Infiltrative diseases: amyloidosis, lymphoma, sarcoidosis, tuberculosis, or hepatic abscess
- Liver metastases
- Allograft rejection after liver transplant
- Alcoholic hepatitis
- Hepatic crisis of sickle cell disease
- Others: IgG4 cholangiopathy, ischemic cholangiopathy, COVID-19
Investigations
- Liver/biliary ultrasound to help differentiate between extrahepatic cholestasis (if biliary dilatation is seen) versus intrahepatic
- For intrahepatic cholestasis
- First order AMA (for PBC), ANA, anti-smooth muscle antibodies
- Then consider MRCP, hepatitis A, B, C, and E testing, and EBV and CMV testing
- Finally, consider liver biopsy
